Research output per year
Research output per year
Project Details
Description
This project aims to develop a quantitative biological approach to the understanding and classification of neuropsychiatric diseases to accelerate the discovery and development of better treatments for patients. As the project coordinator of this EU Innovative Medicine Initiative (IMI) project, we aim to unpick the biological reasons underlying social withdrawal, which is a common early symptom of, Schizophrenia, Alzheimer’s disease and Major Depressive Disorder. The PRISM project started on April 1 2016, and is a EUR €16.5 million public-private cooperation, uniting researchers from European academic centres, and major pharmaceutical companies.
| Short title | Psychiatric Ratings using Intermediate Stratified Markers |
|---|---|
| Acronym | PRISM |
| Status | Finished |
| Effective start/end date | 01/04/2016 → 30/09/2019 |
| Links | http://prism-project.eu |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
-
A new intervention for implementation of pharmacogenetics in psychiatry: A description of the PSY-PGx clinical study
Pelgrim, T. A. D., Philipsen, A., Young, A. H., Juruena, M., Jimenez, E., Vieta, E., Jukić, M., Van der Eycken, E., Heilbronner, U., Moldovan, R., Kas, M. J. H., Jagesar, R. R., Nöthen, M. M., Hoffmann, P., Shomron, N., Kilarski, L. L., van Amelsvoort, T., Campforts, B. & van Westrhenen, R., Feb-2024, In: Pharmaceuticals. 17, 2, 15 p., 151.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Citations (Scopus)75 Downloads (Pure) -
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients
Jongs, N., Penninx, B., Arango, C., Ayuso-Mateos, J. L., van der Wee, N., Rossum, I.W.-V., Saris, I. M. J., van Echteld, A., Koops, S., Bilderbeck, A. C., Raslescu, A., Dawson, G. R., Sommer, B., Marston, H., Vorstman, J. A., Eijkemans, M. J. & Kas, M. J., Jan-2022, In: Journal of Psychiatric Research. 145, p. 302-308 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Citations (Scopus)116 Downloads (Pure) -
Social withdrawal and neurocognitive correlates in schizophrenia
De Donatis, D., Porcelli, S., De Ronchi, D., Merlo Pich, E., Kas, M. J., Bilderbeck, A. & Serretti, A., 1-May-2022, In: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 37, 3, p. 102-109 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Citations (Scopus)119 Downloads (Pure)
Press/Media
-
PRISM project video series
29/08/2019
1 Media contribution
Press/Media: Public Engagement Activities › Professional
-
New research highlights biological similarities between psychiatric and neurodegenerative disorders
06/06/2019
1 item of Media coverage
Press/Media: Research › Professional
-
PRISM Newsletter
29/09/2016 → 30/03/2019
8 Media contributions
Press/Media: Public Engagement Activities › Professional